High Diagnostic Accuracy of Epigenetic Imprinting Biomarkers in Thyroid Nodules.
Xu H, Zhang Y, Wu H, Zhou N, Li X, Pineda JP, Zhu Y, Fu H, Ying M, Yang S, Bao J, Yang L, Zhang B, Guo L, Sun L, Lu F, Wang H, Huang Y, Zhu T, Wang X, Wei Q, Sheng C, Qu S, Lv Z, Xu D, Li Q, Dong Y, Qin J, Cheng T, Xing M.
J Clin Oncol. 2023 Feb 20;41(6):1296-1306. doi: 10.1200/JCO.22.00232. Epub 2022 Nov 15.
Chromogenic in Situ-Hybridization of HPV16/18 DNA in Relation to the Over-Expressed Protein of P73-Gene in Tissues from a Group of Thyroid Carcinoma.
Kadhim Salim N, Hasan Mohammed Ali S, Mahdi Al-Sudani I.
Arch Razi Inst. 2022 Jun 30;77(3):967-975. doi: 10.22092/ARI.2022.357622.2075. eCollection 2022 Jun.
Lymph node thyroglobulin in the diagnosis of metastases of thyroid carcinoma with the thyroid in situ: A prospective intraoperative study.
D'angeli S, Paladino NC, Fargette C, Archange C, Essamet W, Hamidou Z, Palazzo F, Baumstarck K, Sebag F, Taïeb D.
Eur J Surg Oncol. 2023 Apr;49(4):760-763. doi: 10.1016/j.ejso.2022.12.007. Epub 2022 Dec 16.
Detection of NTRK1/3 Rearrangements in Papillary Thyroid Carcinoma Using Immunohistochemistry, Fluorescent In Situ Hybridization, and Next-Generation Sequencing.
Lee YC, Chen JY, Huang CJ, Chen HS, Yang AH, Hang JF.
Endocr Pathol. 2020 Dec;31(4):348-358. doi: 10.1007/s12022-020-09648-9. Epub 2020 Sep 3.
False-positive staining of thyroglobulin distinguished from mixed medullary and follicular thyroid carcinoma by duplex in situ hybridization.
Takeshima K, Ariyasu H, Uraki S, Morita S, Furukawa Y, Inaba H, Iwakura H, Doi A, Warigaya K, Murata SI, Enomoto K, Hotomi M, Akamizu T.
Endocr J. 2020 Oct 28;67(10):1007-1017. doi: 10.1507/endocrj.EJ20-0169. Epub 2020 Jun 10.
Role of CDKN2C Fluorescence In Situ Hybridization in the Management of Medullary Thyroid Carcinoma.
El Naofal M, Kim A, Yon HY, Baity M, Ming Z, Bui-Griffith J, Tang Z, Robinson M, Grubbs EG, Cote GJ, Hu P.
Ann Clin Lab Sci. 2017 Sep;47(5):523-528.
In-situ analysis of calcitonin and CGRP expression in medullary thyroid carcinoma.
Boultwood J, Wynford-Thomas D, Richards GP, Craig RK, Williams ED.
Clin Endocrinol (Oxf). 1990 Sep;33(3):381-90. doi: 10.1111/j.1365-2265.1990.tb00503.x.
A double mutation of BRAF L597Q and V600E in situ and solitary brain metastasis of occult papillary thyroid carcinoma: A case report.
Chen L, Wu Y, Bai H, Liu H, Li X.
Medicine (Baltimore). 2021 Feb 12;100(6):e24458. doi: 10.1097/MD.0000000000024458.
Non-Coding RNAs in Thyroid Cancer.
Zhang R, Hardin H, Chen J, Guo Z, Lloyd RV.
Endocr Pathol. 2016 Mar;27(1):12-20. doi: 10.1007/s12022-016-9417-8.
In situ preservation of the inferior parathyroid gland during central neck dissection for papillary thyroid carcinoma.
Wang JB, Wu K, Shi LH, Sun YY, Li FB, Xie L.
Br J Surg. 2017 Oct;104(11):1514-1522. doi: 10.1002/bjs.10581. Epub 2017 Aug 7.
